Price Alert

Global Cord Blood Corpora... (CO)

NYSE: CO · Real-Time Price · USD

2.99

0.77 (34.68%)

At close: Jun 09, 2023, 3:43 PM

Global Cord Blood Statistics

Share Statistics

Global Cord Blood has 133.91M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	133.91M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	35.63M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 1.08M, so 0% of the outstanding shares have been sold short.

Short Interest	1.08M
Short % of Shares Out	n/a
Short % of Float	2.83%
Short Ratio (days to cover)	999.99

Valuation Ratios

The PE ratio is 5.92 and the forward PE ratio is null. Global Cord Blood's PEG ratio is -4.13.

PE Ratio	5.92
Forward PE	n/a
PS Ratio	2.39
Forward PS	n/a
PB Ratio	0.61
P/FCF Ratio	5
PEG Ratio	-4.13

Financial Ratio History

Enterprise Valuation

Global Cord Blood has an Enterprise Value (EV) of -3.69B.

EV / Sales	-2.97
EV / EBITDA	-5.87
EV / EBIT	-6.02
EV / FCF	-6.22

Financial Position

The company has a current ratio of 10.73, with a Debt / Equity ratio of 0.

Current Ratio	10.73
Quick Ratio	10.66
Debt / Equity	0
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	0

Financial Efficiency

Return on Equity is 10.27% and Return on Invested Capital is 6.26%.

Return on Equity	10.27%
Return on Assets	5.87%
Return on Invested Capital	6.26%
Revenue Per Employee	$1.03M
Profits Per Employee	$416.86K
Employee Count	1,202
Asset Turnover	0.15
Inventory Turnover	4

Taxes

Income Tax	118.35M
Effective Tax Rate	18.85%

Stock Price Statistics

The stock price has increased by 0.08% in the last 52 weeks. The beta is -0.04, so Global Cord Blood's price volatility has been lower than the market average.

Beta	-0.04
52-Week Price Change	0.08%
50-Day Moving Average	2.95
200-Day Moving Average	2.91
Relative Strength Index (RSI)	51.83
Average Volume (20 Days)	177,415

Income Statement

In the last 12 months, Global Cord Blood had revenue of 1.24B and earned 501.06M in profits. Earnings per share was 4.12.

Revenue	1.24B
Gross Profit	1.06B
Operating Income	608.87M
Net Income	501.06M
EBITDA	628.78M
EBIT	608.87M
Earnings Per Share (EPS)	4.12

Full Income Statement

Balance Sheet

The company has 6.66B in cash and 147K in debt, giving a net cash position of 6.66B.

Cash & Cash Equivalents	6.66B
Total Debt	147K
Net Cash	6.66B
Retained Earnings	2.89B
Total Assets	1.35B
Working Capital	991.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 613.61M and capital expenditures -19.79M, giving a free cash flow of 593.82M.

Operating Cash Flow	613.61M
Capital Expenditures	-19.79M
Free Cash Flow	593.82M
FCF Per Share	4.89

Full Cash Flow Statement

Margins

Gross margin is 85.26%, with operating and profit margins of 48.97% and 40.3%.

Gross Margin	85.26%
Operating Margin	48.97%
Pretax Margin	50.5%
Profit Margin	40.3%
EBITDA Margin	50.58%
EBIT Margin	48.97%
FCF Margin	47.76%

Dividends & Yields

CO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	16.88%
FCF Yield	20.01%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for CO.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$64.56
Lynch Upside	2059.2%
Graham Number	61.02
Graham Upside	1940.8%

Scores

Altman Z-Score	4.14
Piotroski F-Score	8